DK0558529T3 - Farmaceutisk præparat til behandling af forlænget koagulationstid - Google Patents

Farmaceutisk præparat til behandling af forlænget koagulationstid

Info

Publication number
DK0558529T3
DK0558529T3 DK91919614.7T DK91919614T DK0558529T3 DK 0558529 T3 DK0558529 T3 DK 0558529T3 DK 91919614 T DK91919614 T DK 91919614T DK 0558529 T3 DK0558529 T3 DK 0558529T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical preparation
clotting time
prolonged clotting
prolonged
Prior art date
Application number
DK91919614.7T
Other languages
English (en)
Inventor
Ole Nordfang
Ulla Hedner
Niels Peter Hundahl Moller
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0558529T3 publication Critical patent/DK0558529T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91919614.7T 1990-10-31 1991-10-18 Farmaceutisk præparat til behandling af forlænget koagulationstid DK0558529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound

Publications (1)

Publication Number Publication Date
DK0558529T3 true DK0558529T3 (da) 1996-06-03

Family

ID=8113744

Family Applications (2)

Application Number Title Priority Date Filing Date
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound
DK91919614.7T DK0558529T3 (da) 1990-10-31 1991-10-18 Farmaceutisk præparat til behandling af forlænget koagulationstid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK261490A DK261490D0 (da) 1990-10-31 1990-10-31 New pharmaceutical compound

Country Status (15)

Country Link
EP (1) EP0558529B1 (da)
JP (1) JPH06502171A (da)
AT (1) ATE132757T1 (da)
AU (1) AU657926B2 (da)
CA (1) CA2095356A1 (da)
CZ (1) CZ282497B6 (da)
DE (1) DE69116380T2 (da)
DK (2) DK261490D0 (da)
ES (1) ES2083597T3 (da)
GR (1) GR3019514T3 (da)
HU (1) HUT64236A (da)
RU (1) RU2127600C1 (da)
SK (1) SK282516B6 (da)
UA (1) UA35567C2 (da)
WO (1) WO1992007584A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
AU636080B1 (en) * 1992-07-21 1993-04-08 Profy International Corporation Unitary loose sheet binder
RU2195676C2 (ru) * 1999-08-26 2002-12-27 Уральская государственная медицинская академия Способ комплексной оценки прогноза эффективности лечения диффузных заболеваний соединительной ткани низкомолекулярными антикоагулянтами
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
DK1282438T3 (da) * 2000-05-10 2005-11-14 Novo Nordisk Healthcare Ag Farmaceutisk sammensætning omfattende en faktor VIIa og en faktor XIII
BR0213293A (pt) 2001-10-15 2004-12-21 Chiron Corp Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
WO2007014749A2 (en) * 2005-07-29 2007-02-08 Universiteit Van Maastricht Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor
KR20110039218A (ko) 2008-06-30 2011-04-15 노보 노르디스크 에이/에스 항－인간 인터루킨－２０ 항체
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
EP2379096B1 (en) 2008-12-19 2019-10-30 Baxalta GmbH Tfpi inhibitors and methods of use
WO2010072691A1 (en) 2008-12-22 2010-07-01 Novo Nordisk A/S Antibodies against tissue factor pathway inhibitor
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
SI3409289T1 (sl) * 2010-02-26 2020-12-31 Novo Nordisk A/S Stabilni sestavki, ki vsebujejo protitelo
PT2542257T (pt) 2010-03-01 2017-10-09 Bayer Healthcare Llc Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi)
ES2983470T3 (es) 2010-03-19 2024-10-23 Takeda Pharmaceuticals Co Inhibidores del TFPI y métodos de uso
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
US9228022B2 (en) 2010-06-30 2016-01-05 Novo Nordisk A/S Antibodies that are capable of specifically binding tissue factor pathway inhibitor
TW201212938A (en) 2010-06-30 2012-04-01 Novo Nordisk As Antibodies that are capable of specifically binding tissue factor pathway inhibitor
BR112014022435B1 (pt) 2012-03-21 2023-02-14 Takeda Pharmaceutical Company Limited Inibidores de tfpi e métodos de uso
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington Method of isolating highly purified tissue factor inhibitor
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
HU219883B (hu) 1988-03-17 2001-08-28 Novo-Nordisk A/S Heparinkötő proteinek, ezeket kódoló DNS és a proteineket tartalmazó gyógyszerkészítmények, valamint eljárás ezek előállítására
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat

Also Published As

Publication number Publication date
DE69116380D1 (de) 1996-02-22
EP0558529A1 (en) 1993-09-08
WO1992007584A1 (en) 1992-05-14
EP0558529B1 (en) 1996-01-10
GR3019514T3 (en) 1996-07-31
CZ282497B6 (cs) 1997-07-16
CA2095356A1 (en) 1992-05-01
ES2083597T3 (es) 1996-04-16
AU8871191A (en) 1992-05-26
DK261490D0 (da) 1990-10-31
CZ78693A3 (en) 1993-12-15
SK42893A3 (en) 1993-09-08
DE69116380T2 (de) 1996-07-11
SK282516B6 (sk) 2002-10-08
HU9301253D0 (en) 1993-07-28
JPH06502171A (ja) 1994-03-10
HUT64236A (en) 1993-12-28
UA35567C2 (uk) 2001-04-16
RU2127600C1 (ru) 1999-03-20
ATE132757T1 (de) 1996-01-15
AU657926B2 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DE69019716D1 (de) Medizinisches Gerät zur Laserbehandlung.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK0428038T3 (da) Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
NO905428L (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
FI921606A0 (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
NO865079D0 (no) Stabiliserte humanvev-plaminogenaktivator-preparater.
NO893637L (no) Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer.
DK0514452T4 (da) Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
ATE201823T1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
EP1065200A4 (en) Aminoisoquinoline DERIVATIVES
DK524489A (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
BR9809478A (pt) Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DE60117762D1 (de) Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
DE69113437D1 (de) Therapeutische Mittel für diabetisches Gangrän.
SE8802040D0 (sv) New use
DE69831981D1 (de) Wässerige Lösung zur Behandlung von Enteroclysis bei hepatischer Enzephalopathie
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.